kabutan

Pharmarise Holdings, First Half Ordinary Profit Increases by 11 times

Thu Dec 25, 2025 12:30 pm JST Earnings

2796 Pharmarise Holdings Corporation 【J-GAAP】

Earnings Report

Pharmarise Holdings Corporation <2796> [TSE Std] announced its financial results at noon (12:30) on December 25th. The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending May 2026 (June to November) surged 11 times that of the same period last year, reaching 328 million yen. However, Progress toward the full-year plan of 941 million yen was 34.9%, also falling below the five-year average of 48.1%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to May period (second half) is expected to surge 5.7 times that of the same period last year, reaching 613 million yen.

In the most recent three-month period, from September to November (2Q), the consolidated ordinary profit surged 36 times that of the same period last year, reaching 213 million yen. The operating profit margin improved from 0.3% in the same period last year to 1.5%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jun - Nov, 2023 26,948 710 701 273 28.3 84.2 Dec 25, 2023 J-GAAP
Jun - Nov, 2024 30,544 100 29 -113 -10.1 21.3 Dec 25, 2024 J-GAAP
Jun - Nov, 2025 33,602 399 328 111 9.8 34.9 Dec 25, 2025 J-GAAP
YoY +10.0% +299.0% +1,031.0% － －

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun - Nov, 2025 Guidance 33,144 390 363 99 8.6 0 Jun 25, 2025 J-GAAP
Jun - Nov, 2025 Results 33,602 399 328 111 9.8 0 Dec 25, 2025 J-GAAP
Revision Rate +1.4% +2.3% -9.6% +12.1% +13.2%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec - May, 2024 32,964 193 107 -254 -22.5 14 Jun 25, 2025 J-GAAP
Dec - May, 2025 Guidance 33,193 724 613 155 13.5 14 Dec 25, 2025 J-GAAP
YoY +0.7% +275.1% +472.9% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2024 54,466 916 833 -351 -33.4 20 Jun 28, 2024 J-GAAP
May, 2025 63,508 293 136 -367 -32.5 14 Jun 25, 2025 J-GAAP
May, 2026 Guidance 66,795 1,123 941 266 23.1 14 Jun 25, 2025 J-GAAP
YoY +5.2% +283.3% +591.9% － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Sep - Nov, 2024 15,313 48 6 18 1.6 0.3 Dec 25, 2024 J-GAAP
Dec - Feb, 2024 16,035 -5 -47 -159 -14.1 0.0 Mar 25, 2025 J-GAAP
Mar - May, 2025 16,929 198 154 -95 -8.4 1.2 Jun 25, 2025 J-GAAP
Jun - Aug, 2025 16,753 152 115 -18 -1.6 0.9 Sep 25, 2025 J-GAAP
Sep - Nov, 2025 16,849 247 213 129 11.3 1.5 Dec 25, 2025 J-GAAP
YoY +10.0% +414.6% +3,450.0% +616.7% +603.7%

Related Articles